In liver diseases, such as nonalcoholic steatohepatitis (NASH), IL‐15‐regulated CXCR6+ CD8+ T cells have been identified, and they accumulate in the liver where they target liver cells.111. Here, CD8A is linked to metabolic dysfunction-associated steatohepatitis.